Business Description
BCAL Diagnostics Ltd
ISIN : AU0000160921
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.34 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 54.3 | |||||
9-Day RSI | 56.62 | |||||
14-Day RSI | 55.81 | |||||
6-1 Month Momentum % | 26.26 | |||||
12-1 Month Momentum % | 56.25 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.21 | |||||
Quick Ratio | 5.21 | |||||
Cash Ratio | 4.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -79.71 | |||||
ROA % | -60.64 | |||||
ROIC % | -392.86 | |||||
ROC (Joel Greenblatt) % | -319.08 | |||||
ROCE % | -97.48 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 5.63 | |||||
Price-to-Tangible-Book | 6.75 | |||||
EV-to-EBIT | -5.74 | |||||
EV-to-EBITDA | -5.98 | |||||
EV-to-FCF | -8.24 | |||||
Price-to-Net-Current-Asset-Value | 6.75 | |||||
Price-to-Net-Cash | 13.5 | |||||
Earnings Yield (Greenblatt) % | -17.41 | |||||
FCF Yield % | -10.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BCAL Diagnostics Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.022 | ||
Beta | 0.69 | ||
Volatility % | 102.2 | ||
14-Day RSI | 55.81 | ||
14-Day ATR (A$) | 0.009849 | ||
20-Day SMA (A$) | 0.11925 | ||
12-1 Month Momentum % | 56.25 | ||
52-Week Range (A$) | 0.07 - 0.21 | ||
Shares Outstanding (Mil) | 314.29 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BCAL Diagnostics Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BCAL Diagnostics Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
BCAL Diagnostics Ltd Frequently Asked Questions
What is BCAL Diagnostics Ltd(ASX:BDX)'s stock price today?
When is next earnings date of BCAL Diagnostics Ltd(ASX:BDX)?
Does BCAL Diagnostics Ltd(ASX:BDX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |